Tiny particles strengthen the compound used to fill teeth and ward off infection.
Nine UC members elected to National Academy of Medicine
Members elected from three UC campuses: Davis, San Diego, San Francisco.
Beauty's hidden health cost for African Americans
Ph.D. student raises awareness about potential health risks of certain hair products.
Six things parents and athletes need to know about concussions
Which sports have a higher risk of concussion? What should you do if a concussion is suspected? What steps should you follow before returning to play?
Making a splash: first look at concussions in water polo
UC Irvine physiologist James Hicks, whose three sons played water polo, is leading the first probe of concussions in water polo.
UC tackles concussions
From expanding awareness in youth sports to conducting groundbreaking studies of collegiate athletes and military personnel, UC experts lead in advancing knowledge about traumatic brain injury and improving care.
The diagnosis that rocked football
UC Davis pathologist Bennet Omalu was the first to report cases of chronic traumatic encephalopathy in professional football players; the story of his discovery is the subject of the upcoming movie 'Concussion' starring Will Smith.
Fighting breast cancer, message by message
UC Merced’s Susana Ramirez will lead a five-year project to create messages to help bicultural Latinas improve their eating habits and reduce their risk of breast cancer.
‘Window to the brain’ research ramps up
Partnership with three Mexican universities receives nearly $5 million to further study method that could make it easier to treat brain conditions.
Eating organic lowers pesticide levels in children
New research from UC Berkeley shows that switching from conventional to organic fruits and vegetables, even for just a few days, significantly reduces pesticide levels in children’s bodies.
A pediatric cancer drug three decades in the making
Experimental immunotherapy treatment first successfully used in the 1990s is finally available for commercial use.
UCSF researcher unveils promising new drug for MS patients
Late-phase trials found that the drug greatly reduced symptoms for progressive multiple sclerosis as well as a more common form of the disease.